Woolley P V, Pinsky S D
Cancer. 1981 Mar 15;47(6 Suppl):1485-9. doi: 10.1002/1097-0142(19810315)47:6+<1485::aid-cncr2820471408>3.0.co;2-v.
Carcinoma of the pancreas can be produced in guinea pigs by the oral administration of 1-methyl-1-nitrosourea (MNU). Our present studies have examined the distribution of this compound in these animals following parenteral and oral administration and also its specific sites of binding within the pancreatic cell. Emphasis has been placed upon the comparison of the uptake and binding of MNU with the related compound 1-methyl-3-nitro-1-nitrosoguanidine (MNNG), which does not seem to be carcinogenic to the pancreas after oral administration. The distribution data indicate uptake into pancreas that is comparable to that of other organs. Binding data show both MNU and MNNG to extensively modify subcellular organelles and the DNA and proteins of chromatin, but that MNU does this to a somewhat greater extent than MNNG.
通过口服1-甲基-1-亚硝基脲(MNU)可在豚鼠体内诱发胰腺癌。我们目前的研究检测了该化合物经肠胃外和口服给药后在这些动物体内的分布情况,以及它在胰腺细胞内的特定结合位点。重点在于比较MNU与相关化合物1-甲基-3-硝基-1-亚硝基胍(MNNG)的摄取和结合情况,口服MNNG后似乎对胰腺无致癌性。分布数据表明,胰腺对MNU的摄取与其他器官相当。结合数据显示,MNU和MNNG均可广泛修饰亚细胞器以及染色质的DNA和蛋白质,但MNU在这方面的作用程度略大于MNNG。